Fayez Sarofim & Co’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.11M | Sell |
12,795
-15,300
| -54% | -$1.47M | ﹤0.01% | 178 |
|
|
2025
Q4 | $2.7M | Sell |
28,095
-28
| -0.1% | -$2.72K | 0.01% | 141 |
|
|
2025
Q3 | $2.68M | Buy |
28,123
+28
| +0.1% | +$2.57K | 0.01% | 142 |
|
|
2025
Q2 | $2.45M | Hold |
28,095
| – | – | 0.01% | 144 |
|
|
2025
Q1 | $2.52M | Sell |
28,095
-4,000
| -12% | -$358K | 0.01% | 141 |
|
|
2024
Q4 | $2.56M | Hold |
32,095
| – | – | 0.01% | 146 |
|
|
2024
Q3 | $2.89M | Hold |
32,095
| – | – | 0.01% | 136 |
|
|
2024
Q2 | $2.53M | Buy |
32,095
+3,000
| +10% | +$246K | 0.01% | 136 |
|
|
2024
Q1 | $2.54M | Sell |
29,095
-267
| -0.9% | -$22.8K | 0.01% | 138 |
|
|
2023
Q4 | $2.5M | Sell |
29,362
-19,800
| -40% | -$1.51M | 0.01% | 135 |
|
|
2023
Q3 | $3.85M | Hold |
49,162
| – | – | 0.01% | 119 |
|
|
2023
Q2 | $4.33M | Sell |
49,162
-6,780
| -12% | -$584K | 0.02% | 116 |
|
|
2023
Q1 | $4.51M | Buy |
55,942
+537
| +1% | +$43.8K | 0.02% | 113 |
|
|
2022
Q4 | $4.31M | Sell |
55,405
-540
| -1% | -$43.8K | 0.02% | 112 |
|
|
2022
Q3 | $4.52M | Sell |
55,945
-1,719
| -3% | -$154K | 0.02% | 111 |
|
|
2022
Q2 | $5.18M | Sell |
57,664
-4,789
| -8% | -$485K | 0.02% | 113 |
|
|
2022
Q1 | $6.93M | Sell |
62,453
-4,699
| -7% | -$496K | 0.02% | 110 |
|
|
2021
Q4 | $6.95M | Buy |
67,152
+9,693
| +17% | +$1.12M | 0.02% | 110 |
|
|
2021
Q3 | $7.2M | Sell |
57,459
-748
| -1% | -$96.8K | 0.02% | 106 |
|
|
2021
Q2 | $7.22M | Sell |
58,207
-1,153
| -2% | -$145K | 0.02% | 105 |
|
|
2021
Q1 | $7.01M | Sell |
59,360
-130
| -0.2% | -$15.2K | 0.03% | 96 |
|
|
2020
Q4 | $6.97M | Buy |
59,490
+33,927
| +133% | +$3.73M | 0.03% | 97 |
|
|
2020
Q3 | $2.66M | Sell |
25,563
-989
| -4% | -$99.3K | 0.01% | 125 |
|
|
2020
Q2 | $2.43M | Buy |
26,552
+731
| +3% | +$70.1K | 0.01% | 128 |
|
|
2020
Q1 | $2.33M | Buy |
25,821
+476
| +2% | +$50.6K | 0.01% | 120 |
|
|
2019
Q4 | $2.88M | Sell |
25,345
-42,048
| -62% | -$4.61M | 0.01% | 127 |
|
|
2019
Q3 | $7.32M | Buy |
67,393
+686
| +1% | +$71.6K | 0.04% | 93 |
|
|
2019
Q2 | $6.5M | Sell |
66,707
-243
| -0.4% | -$22.2K | 0.03% | 101 |
|
|
2019
Q1 | $6.1M | Sell |
66,950
-117
| -0.2% | -$10.5K | 0.03% | 103 |
|
|
2018
Q4 | $6.1M | Buy |
67,067
+800
| +1% | +$74.8K | 0.04% | 98 |
|
|
2018
Q3 | $6.52M | Sell |
66,267
-1
| -0% | -$92 | 0.03% | 98 |
|
|
2018
Q2 | $5.67M | Buy |
66,268
+306
| +0.5% | +$25.6K | 0.03% | 103 |
|
|
2018
Q1 | $5.29M | Hold |
65,962
| – | – | 0.03% | 103 |
|
|
2017
Q4 | $5.33M | Buy |
65,962
+41
| +0.1% | +$3.28K | 0.03% | 100 |
|
|
2017
Q3 | $5.13M | Sell |
65,921
-150
| -0.2% | -$12.5K | 0.03% | 103 |
|
|
2017
Q2 | $5.86M | Sell |
66,071
-1,915
| -3% | -$161K | 0.03% | 102 |
|
|
2017
Q1 | $5.48M | Hold |
67,986
| – | – | 0.03% | 105 |
|
|
2016
Q4 | $4.84M | Sell |
67,986
-1,256
| -2% | -$98.7K | 0.03% | 109 |
|
|
2016
Q3 | $5.98M | Buy |
69,242
+600
| +0.9% | +$52.3K | 0.03% | 105 |
|
|
2016
Q2 | $5.96M | Buy |
68,642
+345
| +0.5% | +$27.9K | 0.03% | 103 |
|
|
2016
Q1 | $5.12M | Sell |
68,297
-210
| -0.3% | -$15.8K | 0.03% | 104 |
|
|
2015
Q4 | $5.27M | Sell |
68,507
-176
| -0.3% | -$13.2K | 0.03% | 104 |
|
|
2015
Q3 | $4.6M | Sell |
68,683
-1,400
| -2% | -$103K | 0.03% | 106 |
|
|
2015
Q2 | $5.19M | Sell |
70,083
-1,300
| -2% | -$99.3K | 0.03% | 103 |
|
|
2015
Q1 | $5.57M | Buy |
71,383
+293
| +0.4% | +$22.2K | 0.03% | 101 |
|
|
2014
Q4 | $5.13M | Sell |
71,090
-32,370
| -31% | -$2.25M | 0.02% | 103 |
|
|
2014
Q3 | $6.41M | Sell |
103,460
-55,452
| -35% | -$3.53M | 0.03% | 96 |
|
|
2014
Q2 | $10.1M | Sell |
158,912
-102,030
| -39% | -$6.2M | 0.05% | 87 |
|
|
2014
Q1 | $16.1M | Sell |
260,942
-15,120
| -5% | -$881K | 0.08% | 80 |
|
|
2013
Q4 | $15.8M | Buy |
+276,062
| New | +$15.7M | 0.07% | 79 |
|
|
2013
Q2 | $32M | Buy |
+621,644
| New | +$30.7M | 0.16% | 66 |
|
Other funds holding MDT
VCM
VPM
Fayez Sarofim & Co's MDT Position: Q1 2026 in Review
Fayez Sarofim & Co reduced its Medtronic (MDT) stake by 54% in Q1 2026, selling an estimated $1.47M and leaving 12,795 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #178.
Fayez Sarofim & Co first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $32M in Q2 2013. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Fayez Sarofim & Co held 12,795 shares of Medtronic worth $1.11M as of Q1 2026.
- Fayez Sarofim & Co sold 15,300 Medtronic shares in Q1 2026, an estimated $1.47M.
- Medtronic made up ﹤0.01% of Fayez Sarofim & Co's portfolio in Q1 2026, its #178 holding.
- Fayez Sarofim & Co first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
- Fayez Sarofim & Co's Medtronic position peaked at $32M in Q2 2013.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Fayez Sarofim & Co's 13F filing for Q1 2026, filed 15 May 2026.